cbsn fusion experimental melanoma vaccine shows promising results thumbnail

Doctors explain how Moderna’s melanoma mRNA vaccine could fight deadliest form of skin cancer

Moderna is touting a “landmark moment” in its experimental melanoma treatment, saying its vaccine could help prevent the deadly skin cancer from returning or spreading. The groundbreaking clinical trial studied over 1,100 people whose melanoma was in advanced stages, taking a piece of a patient’s tumor and using it to build a shot, CBS News…

Read More
gettyimages 2287299632

Moderna stock more than doubles after melanoma vaccine trial shows “landmark moment”

Drugmaker Moderna’s stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat melanoma, the deadly skin cancer from which more than 8,500 people are expected to die this year. Moderna and Merck, its drug development partner, said the novel treatment prevented melanoma from returning or spreading in a…

Read More